Biocon Biologics Uk Plc

This study tests a new drug called Bmab3000, which is similar to an approved breast cancer drug (Herceptin Hylecta). It involves 150 healthy men aged 18-65 who receive a single injection of either the new or the approved drug. The goal is to compare how the body processes each dr…